slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 44,791-44,820
Pages 10,126
Rows per page 30
Component
44,791-44,820 of 303,780
35
The slide uses a process flow diagram at the top to show the workflow stages, followed by three specific hardware solutions.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
37
The slide uses a circular process flow to represent the R&D pipeline.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
39
Kaplan-Meier survival curves comparing PFS1 (prior treatment) vs PFS2 (study treatment).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
41
The slide uses a complex visual mapping to show drug response across two different biological models (patient samples vs cell lines).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
42
The slide uses a small multiples approach to show dose-response curves for individual patient samples, followed by a summary box plot on the right.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
46
The slide outlines a standard oncology clinical trial design (dose escalation followed by expansion).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
47
The slide uses a human anatomy diagram to map specific cancer types to their respective organs, providing a visual representation of the addressable market.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
48
The slide uses a biological pathway diagram to explain the mechanism of action and a honeycomb diagram to illustrate market breadth.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
49
The slide uses a three-column layout to define technical requirements for a pharmaceutical product.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
50
The table uses a color-coded heatmap to indicate performance against criteria (green=pass, yellow=minor deviation, red=major deviation).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
51
The slide presents preclinical efficacy data for a CDK7 inhibitor ('617) in ovarian (OVCAR3) and triple-negative breast cancer (HCC70) models.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
52
The waterfall plot shows sensitivity vs resistance. The right side shows a volcano plot for pathway analysis and a conceptual diagram for combination testing.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
53
The slide uses a combination of a bar chart for single-agent sensitivity and a heatmap for combination synergy results.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
54
The slide uses a Venn diagram to show gene overlap and line charts to show dose-response relationships for POLR2A and HNRNPDL.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
56
The slide uses a bar chart to demonstrate efficacy (reduction in PLN weight) at different doses of EXS4318 compared to a failed competitor drug.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
57
The slide uses a traffic-light color coding system to highlight the superior profile of EXS4318 compared to failed competitors.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
58
The slide uses a process-flow layout with icons and bulleted lists for each stage.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
59
The slide features a 3D molecular model, likely representing the target protein or the drug-target complex.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
60
The slide highlights the potential for '539 to address brain metastases in SCLC patients.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
61
The diagram illustrates the interaction network of LSD1 with various suppressors and activators.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
62
The slide uses a biological process diagram to explain the mechanism of action for an LSD1 inhibitor.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
63
The slide uses a process flow diagram to explain the therapeutic strategy.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
64
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
65
The slide uses a three-column layout to define the strategic design requirements for a drug candidate.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
66
The slide uses a color-coded heatmap (green/yellow/red/grey) to indicate performance against criteria.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
67
The slide uses a horizontal process flow to map out the stages from initiation to synthesis.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
68
The slide uses a Pareto front to illustrate the trade-off between CNS score and Potency, highlighting that the 'best' molecules are not always the most information-rich.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
69
The slide uses two distinct chart types (dot plot and line chart) to demonstrate the safety profile of a reversible inhibitor compared to an irreversible one.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
70
The slide uses box plots for aggregate data and line charts for individual patient sample responses, categorized by differentiation potential.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits
71
The chart compares single-agent activity (bar chart) against combination synergy (heatmap).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action2 hits